网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
miR-150-3p靶向CDH2基因对缺氧性肺动脉高压新生大鼠肺组织损伤的影响
作者:蔡冬  周丽霞  祁秋霞 
单位:海南省人民医院 新生儿科, 海南 海口 570100
关键词:缺氧性肺动脉高压 肺组织损伤 新生大鼠 miR-150-3p CDH2基因 
分类号:R544.1;R563
出版年·卷·期(页码):2022·50·第九期(1117-1123)
摘要:

目的:探究miR-150-3p靶向CDH2基因对缺氧性肺动脉高压(HPH)新生大鼠肺组织损伤的影响。方法:将新生Wistar大鼠随机分为对照组、模型组、阴性对照组和miR-150-3p过表达组,每组10只。除对照组外,其余各组构建新生大鼠HPH模型。分别检测各组大鼠缺氧3、6、12 d时的平均肺动脉压(mPAP),酶联免疫吸附测定法(ELISA)检测大鼠血清中缺氧诱导因子-1α(HIF-1α)和内皮素-1(ET-1)水平;在缺氧12 d时,Western blotting检测大鼠肺组织HIF-1α、ET-1、诱导型一氧化氮合酶(iNOS)和钙黏蛋白2(CDH2)表达情况,实时荧光定量PCR (RT-PCR)检测大鼠肺组织miR-150-3p、CDH2 mRNA表达。双荧光素酶报告基因实验验证miR-150-3p与CDH2之间的靶向关系。结果:与对照组相比,模型组和阴性对照组大鼠出现反应迟钝、萎靡不振、食量减少、肺组织炎症细胞浸润、肺泡大小改变等现象;大鼠mPAP,血清HIF-1α、ET-1水平,肺组织HIF-1α、ET-1、iNOS和CDH2蛋白表达均明显升高(P<0.05);肺组织miR-150-3p表达明显降低,CDH2 mRNA表达明显升高(P<0.05)。与模型组、相比,阴性对照组上述指标均无显著差异(P>0.05)。与模型组、阴性对照组相比,miR-150-3p过表达组大鼠反应迟钝、炎症细胞浸润等不良现象均获得良好改善,且大鼠mPAP,血清HIF-1α、ET-1水平,肺组织HIF-1α、ET-1、iNOS和CDH2蛋白表达均降低(P<0.05);肺组织miR-150-3p表达明显升高,CDH2 mRNA表达明显降低(P<0.05)。双荧光素酶报告基因实验结果证明CDH2为miR-150-3p的靶基因。结论:miR-150-3p能够通过靶向CDH2基因减轻HPH新生大鼠肺组织损伤。

Objective: To explore the effect of miR-150-3p targeting CDH2 gene on lung tissue damage in neonatal rats with hypoxia-induced pulmonary hypertension(HPH). Methods: Newborn Wistar rats were randomly divided into control group, model group, negative control group, and miR-150-3p overexpression group, with 10 rats in each group. Except for the control group, the rest of the groups constructed a newborn rat HPH model. The mean pulmonary arterial pressure(mPAP) of rats in each group was measured when hypoxia for 3, 6, and 12 d. Enzyme-linked immunosorbent assay(ELISA) was used to detect the levels of hypoxia inducible factor-1α(HIF-1α) and endothelin-1(ET-1) in rat serum; on the 12th day of hypoxia, Western blotting was used to detect the expression of HIF-1α, ET-1, iNOS and CDH2 in the lung tissue of rats, RT-PCR was used to detect the expression of miR-150-3p and CDH2 mRNA in the lung tissue of rats. The dual luciferase reporter gene experiment was used to verify the targeting relationship between miR-150-3p and CDH2. Results: Compared with the control group, rats in the model group and the negative control group showed slow response, malaise, reduced appetite, lung tissue inflammatory cell infiltration, and alveolar size changes; mPAP, the levels of serum HIF-1α and ET-1, the expression of HIF-1α, ET-1, iNOS and CDH2 proteins in lung tissue were all significantly increased(P<0.05), the expression of miR-150-3p in lung tissue was significantly reduced, and the expression of CDH2 mRNA was significantly increased(P<0.05). Compared with the model group, there was no significant difference in the above indicators of the negative control group(P>0.05). Compared with the model group and the negative control group, the rats in the miR-150-3p overexpression group showed a good improvement in slow response and inflammatory cell infiltration; mPAP, the levels of serum HIF-1α and ET-1, the expression of HIF-1α, ET-1, iNOS and CDH2 proteins in lung tissue were all significantly decreased(P<0.05), the expression of miR-150-3p in lung tissue was significantly reduced, and the expression of CDH2 mRNA was significantly decreased(P<0.05). The results of the dual luciferase reporter gene experiment proved that CDH2 was the target gene of miR-150-3p. Conclusion: MiR-150-3p can reduce lung tissue damage in newborn rats with HPH by targeting CDH2 gene.

参考文献:

[1] 程锦, 孙闯, 薛玉刚.利奥西呱联合西地那非治疗先天性心脏病合并肺动脉高压的临床疗效观察[J].现代医学, 2020, 48(4):512-515.
[2] WANG L, LIU J, WANG W, et al.Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin[J].Thorax, 2019, 74(6):564-578.
[3] LI Y, REN W, WANG X, et al.MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension[J].Biomed Pharmacother, 2019, 109(1):1740-1749.
[4] 赵婷, 王彦梅, 王乐, 等.谷氨酰胺诱导热休克蛋白70在缺氧性肺动脉高压新生大鼠中的保护作用研究[J].新疆医科大学学报, 2019, 42(12):1538-1548.
[5] 于秀石, 朱佳, 魏丽丽, 等.IGF-1上调miR-155表达对新生大鼠缺氧性肺动脉高压肺组织损伤的影响及其作用机制[J].中国比较医学杂志, 2019, 29(12):32-38.
[6] 王乐, 吴海燕, 李明霞, 等.热休克蛋白70对新生大鼠缺氧性肺动脉高压的保护作用[J].中国当代儿科杂志, 2017, 19(1):88-94.
[7] SUN J, WANG D, LI X, et al.Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706[J].Cancer Biomark, 2017, 21(1):203-210.
[8] QIU X, LIN J, LIANG B, et al.Identification of hub genes and micrornas associated with idiopathic pulmonary arterial hypertension by integrated bioinformatics analyses[J].Front Genet, 2021, 12(1):1-11.
[9] BUENO-BETI C, HADRI L, HAJJAR R J, et al.The sugen 5416/Hypoxia mouse model of pulmonary arterial hypertension[J].Methods Mol Biol, 2018, 1816(1):243-252.
[10] HU H, ZHANG R, DONG L, et al.Overexpression of ACE2 prevents hypoxia-induced pulmonary hypertension in rats by inhibiting proliferation and immigration of PASMCs[J].Eur Rev Med Pharmacol, 2020, 24(7):3968-3980.
[11] LI H, ZHANG P, LI F, et al.Plasma miR-22-5p, miR-132-5p, and miR-150-3p are associated with acute myocardial infarction[J].Biomed Res Int, 2019, 24(8):1-13.
[12] TAN Z, JIA J, JIANG Y.MiR-150-3p targets SP1 and suppresses the growth of glioma cells[J].Biosci Rep, 2018, 38(3):1-11.
[13] LI P, YAO Y, MA Y, et al.MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3[J].Int Immunopharmacol, 2019, 75(6):13-21.
[14] WANG L, PENG Q, SAI B, et al.Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration[J].J Cancer, 2020, 11(14):4123-4131.
[15] ZOU Z, WANG Q, ZHOU M, et al.Protective effects of P2X7R antagonist in sepsis-induced acute lung injury in mice via regulation of circ_0001679 and circ_0001212 and downstream Pln, Cdh2, and Nprl3 expression[J].J Gene Med, 2020, 22(12):e3261.
[16] KOJIMA H, TOKUNOU T, TAKAHARA Y, et al.Hypoxia-inducible factor-1α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension[J].Physiol Rep, 2019, 7(7):e14025.
[17] LIU J, WANG W, WANG L, et al.IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1α and VEGF expression in vascular endothelial cells[J].EBioMedicine, 2018, 33(1):196-210.
[18] BARTON M, YANAGISAWA M.Endothelin:30 years from discovery to therapy[J].Hypertension, 2019, 74(6):1232-1265.
[19] VETESKOVA J, KMECOVA Z, MALIKOVA E, et al.Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension[J].Exp Lung Res, 2019, 45(1-2):30-41.
[20] LONG M, ZHU X, WANG Q, et al.PM2.5 exposure induces vascular dysfunction via NO generated by iNOS in lung of ApoE-/-mouse[J].Int J Biol, 2020, 16(1):49-60.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 601123 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541